Last updated on: 12 May 2026, 5:54 PM

Goldline Pharmaceutical Limited IPO

BSE SME Live
Offer Date: May 12, 2026 - May 14, 2026

₹ 258000 /6000 Shares
Minimum Investment

Goldline Pharmaceutical Limited IPO subscription status: 22.35 times on (12 May 2026, 5:54 PM); QIB 1.31x, NII 24.46x, and Individual 34.07x.

Subscription Details (No. of Shares)

Category Offer Applied Times
QIBs 540000 705000 1.31
NIIs 390000 9540000 24.46
BNIIs (>10L) 260000 5811000 22.35
SNIIs (<10L) 132000 3729000 28.25
Individual 900000 30660000 34.07
Total 1830000 40905000 22.35
Total Applications5726 apprx

Application Wise Breakup (Approx.)

Category Reserve Applied Times
BNIIs (>10L) 29 228 7.86
SNIIs (<10L) 14 387 27.64
Individual 150 5110 34.07
Total Applications5726 apprx

Subscription Details (In Crores)

Category Offered Demand Times
QIBs 2.32 3.03 1.31
FIIs - 3.03 -
DIIs - 0.00 -
Mutual Funds - 0.00 -
Others - 0.00 -
NIIs 1.68 41.02 24.46
BNIIs (>10L) 1.12 24.99 22.35
SNIIs (<10L) 0.57 16.03 28.25
Individual 3.87 131.84 34.07
TOTAL 7.87 175.89 22.35
Important Disclaimer

Data Source: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites.

Purpose: The information / data provided herein is for informational purposes only and is provided by ipoji.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied.

Accuracy: ipoji.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites.

Liability: ipoji.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. ipoji.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites.

User Responsibility: The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.